Robust Dialog State Tracking for Large Ontologies

The Dialog State Tracking Challenge 4 (DSTC 4) differentiates itself from the previous three editions as follows: the number of slot-value pairs present in the ontology is much larger, no spoken language understanding output is given, and utterances are labeled at the subdialog level. This paper describes a novel dialog state tracking method designed to work robustly under these conditions, using elaborate string matching, coreference resolution tailored for dialogs and a few other improvements. The method can correctly identify many values that are not explicitly present in the utterance. On the final evaluation, our method came in first among 7 competing teams and 24 entries. The F1-score achieved by our method was 9 and 7 percentage points higher than that of the runner-up for the utterance-level evaluation and for the subdialog-level evaluation, respectively.Comment: Paper accepted at IWSDS 201

A tractable DDN-POMDP Approach to Affective Dialogue Modeling for General Probabilistic Frame-based Dialogue Systems

We propose a new approach to developing a tractable affective dialogue model for general probabilistic frame-based dialogue systems. The dialogue model, based on the Partially Observable Markov Decision Process (POMDP) and the Dynamic Decision Network (DDN) techniques, is composed of two main parts, the slot level dialogue manager and the global dialogue manager. Our implemented dialogue manager prototype can handle hundreds of slots; each slot might have many values. A first evaluation of the slot level dialogue manager (1-slot case) showed that with a 95% confidence level the DDN-POMDP dialogue strategy outperforms three simple handcrafted dialogue strategies when the user's action error is induced by stress

A POMDP approach to Affective Dialogue Modeling

We propose a novel approach to developing a dialogue model that is able to take into account some aspects of the user's affective state and to act appropriately. Our dialogue model uses a Partially Observable Markov Decision Process approach with observations composed of the observed user's affective state and action. A simple example of route navigation is explained to clarify our approach. The preliminary results showed that: (1) the expected return of the optimal dialogue strategy depends on the correlation between the user's affective state & the user's action and (2) the POMDP dialogue strategy outperforms five other dialogue strategies (the random, three handcrafted and greedy action selection strategies)

Rapid Dialogue Prototyping Methodology

The objective of this document is to present a rapid dialogue prototyping methodology developed at the Artificial Intelligent Laboratory - Ecole Polytechnique Fédérale de Lausanne. Concretely, the rapid dialogue prototyping methodology is decomposed into 5 consecutive main steps: (1) producing the task model; (2) deriving the initial dialogue model; (3) using a Wizard-of-Oz experiment to instantiate the initial dialogue model; (4) using an internal field test to refine the dialogue model; and (5) using an external field test to evaluate the final dialogue model

Effectiveness of cervical pessary compared to cervical cerclage with or without vaginal progesterone for the prevention of preterm birth in women with twin pregnancies and a short cervix : Study protocol for a two-by-two factorial randomised clinical trial

Peer reviewedPublisher PD

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke